 | • レポートコード：QYR9N7226 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、胃炎治療薬のグローバル市場について調査・分析したレポートで、種類別（酸遮断薬、抗生物質、制酸剤、ヒスタミンブロッカー、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・胃炎治療薬の世界市場規模 ・主要企業別市場シェア ・胃炎治療薬の世界市場規模：種類別（酸遮断薬、抗生物質、制酸剤、ヒスタミンブロッカー、その他） ・胃炎治療薬の世界市場規模：用途別（病院、診療所、その他） ・胃炎治療薬のアメリカ市場規模（種類別、用途別） ・胃炎治療薬のヨーロッパ市場規模（種類別、用途別） ・胃炎治療薬の中国市場規模（種類別、用途別） ・胃炎治療薬の日本市場規模（種類別、用途別） ・胃炎治療薬の東南アジア市場規模（種類別、用途別） ・胃炎治療薬のインド市場規模（種類別、用途別） ・胃炎治療薬の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・胃炎治療薬の世界市場予測（2019年-2025年） ・胃炎治療薬の地域別市場予測（2019年-2025年） ... |
Gastritis is inflammation of the lining of the stomach. It may occur as a short episode or may be of a long duration. There may be no symptoms but, when symptoms are present, the most common is upper abdominal pain. Other possible symptoms include nausea and vomiting, bloating, loss of appetite and heartburn. Complications may include bleeding, stomach ulcers, and stomach tumors.The Americas is going to account for the largest share for gastritis treatment market. Drivers such as widespread of fast food chains in this region along with the increasing sedentary life culture which in turn contributes to increasing patient pool of gastritis and rising geriatric population are likely to enhance the growth of gastritis treatment market.
Europe is the second market leader and holds a healthy share in the global gastritis treatment market. The European market is expected to exhibit a sturdy growth rate during the forecast period owing to the availability of advanced treatment facilities, established healthcare infrastructure along with the presence of a flourishing medical device market which helps in efficient and accurate diagnosis. Furthermore, due to the increasing number of lactose-intolerant issues, vulnerability to falling prey of gastritis is more likely to lead to an increasing number of gastritis sufferers. Thus, fueling the market growth during the forecast period.
Asia-Pacific is expected to be the fastest emerging market owing to increasing government initiatives for healthcare reform, increasing adaption of a sedentary lifestyle, and increasing prevalence of gastritis. Moreover, the prevalence of multifocal atrophic gastritis and gastric adenocarcinomas is high in these regions. Furthermore, the presence of renowned domestic pharmaceutical players, as well as the increasing healthcare spending per capita, is going to accelerate the market growth during the forecast period.
In 2018, the global Gastritis Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Gastritis Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gastritis Therapeutics development in United States, Europe and China.
The key players covered in this study
Pfizer
AstraZeneca
Novartis
Cipla
Abbott Laboratories
Microbiotix
Reddy’s Laboratories
Lupin Ltd
Perrigo Pharmaceutical
Sun Pharmaceutical Industries
Market segment by Type, the product can be split into
Acid-Blocking Medicines
Antibiotics
Antacids
Histamine Blockers
Others
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Gastritis Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Gastritis Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Gastritis Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Gastritis Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Acid-Blocking Medicines
1.4.3 Antibiotics
1.4.4 Antacids
1.4.5 Histamine Blockers
1.4.6 Others
1.5 Market by Application
1.5.1 Global Gastritis Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Gastritis Therapeutics Market Size
2.2 Gastritis Therapeutics Growth Trends by Regions
2.2.1 Gastritis Therapeutics Market Size by Regions (2014-2025)
2.2.2 Gastritis Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Gastritis Therapeutics Market Size by Manufacturers
3.1.1 Global Gastritis Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Gastritis Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Gastritis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Gastritis Therapeutics Key Players Head office and Area Served
3.3 Key Players Gastritis Therapeutics Product/Solution/Service
3.4 Date of Enter into Gastritis Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Gastritis Therapeutics Market Size by Type (2014-2019)
4.2 Global Gastritis Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Gastritis Therapeutics Market Size (2014-2019)
5.2 Gastritis Therapeutics Key Players in United States
5.3 United States Gastritis Therapeutics Market Size by Type
5.4 United States Gastritis Therapeutics Market Size by Application
6 Europe
6.1 Europe Gastritis Therapeutics Market Size (2014-2019)
6.2 Gastritis Therapeutics Key Players in Europe
6.3 Europe Gastritis Therapeutics Market Size by Type
6.4 Europe Gastritis Therapeutics Market Size by Application
7 China
7.1 China Gastritis Therapeutics Market Size (2014-2019)
7.2 Gastritis Therapeutics Key Players in China
7.3 China Gastritis Therapeutics Market Size by Type
7.4 China Gastritis Therapeutics Market Size by Application
8 Japan
8.1 Japan Gastritis Therapeutics Market Size (2014-2019)
8.2 Gastritis Therapeutics Key Players in Japan
8.3 Japan Gastritis Therapeutics Market Size by Type
8.4 Japan Gastritis Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Gastritis Therapeutics Market Size (2014-2019)
9.2 Gastritis Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Gastritis Therapeutics Market Size by Type
9.4 Southeast Asia Gastritis Therapeutics Market Size by Application
10 India
10.1 India Gastritis Therapeutics Market Size (2014-2019)
10.2 Gastritis Therapeutics Key Players in India
10.3 India Gastritis Therapeutics Market Size by Type
10.4 India Gastritis Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Gastritis Therapeutics Market Size (2014-2019)
11.2 Gastritis Therapeutics Key Players in Central & South America
11.3 Central & South America Gastritis Therapeutics Market Size by Type
11.4 Central & South America Gastritis Therapeutics Market Size by Application
12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Gastritis Therapeutics Introduction
12.1.4 Pfizer Revenue in Gastritis Therapeutics Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 AstraZeneca
12.2.1 AstraZeneca Company Details
12.2.2 Company Description and Business Overview
12.2.3 Gastritis Therapeutics Introduction
12.2.4 AstraZeneca Revenue in Gastritis Therapeutics Business (2014-2019)
12.2.5 AstraZeneca Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Gastritis Therapeutics Introduction
12.3.4 Novartis Revenue in Gastritis Therapeutics Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 Cipla
12.4.1 Cipla Company Details
12.4.2 Company Description and Business Overview
12.4.3 Gastritis Therapeutics Introduction
12.4.4 Cipla Revenue in Gastritis Therapeutics Business (2014-2019)
12.4.5 Cipla Recent Development
12.5 Abbott Laboratories
12.5.1 Abbott Laboratories Company Details
12.5.2 Company Description and Business Overview
12.5.3 Gastritis Therapeutics Introduction
12.5.4 Abbott Laboratories Revenue in Gastritis Therapeutics Business (2014-2019)
12.5.5 Abbott Laboratories Recent Development
12.6 Microbiotix
12.6.1 Microbiotix Company Details
12.6.2 Company Description and Business Overview
12.6.3 Gastritis Therapeutics Introduction
12.6.4 Microbiotix Revenue in Gastritis Therapeutics Business (2014-2019)
12.6.5 Microbiotix Recent Development
12.7 Reddy’s Laboratories
12.7.1 Reddy’s Laboratories Company Details
12.7.2 Company Description and Business Overview
12.7.3 Gastritis Therapeutics Introduction
12.7.4 Reddy’s Laboratories Revenue in Gastritis Therapeutics Business (2014-2019)
12.7.5 Reddy’s Laboratories Recent Development
12.8 Lupin Ltd
12.8.1 Lupin Ltd Company Details
12.8.2 Company Description and Business Overview
12.8.3 Gastritis Therapeutics Introduction
12.8.4 Lupin Ltd Revenue in Gastritis Therapeutics Business (2014-2019)
12.8.5 Lupin Ltd Recent Development
12.9 Perrigo Pharmaceutical
12.9.1 Perrigo Pharmaceutical Company Details
12.9.2 Company Description and Business Overview
12.9.3 Gastritis Therapeutics Introduction
12.9.4 Perrigo Pharmaceutical Revenue in Gastritis Therapeutics Business (2014-2019)
12.9.5 Perrigo Pharmaceutical Recent Development
12.10 Sun Pharmaceutical Industries
12.10.1 Sun Pharmaceutical Industries Company Details
12.10.2 Company Description and Business Overview
12.10.3 Gastritis Therapeutics Introduction
12.10.4 Sun Pharmaceutical Industries Revenue in Gastritis Therapeutics Business (2014-2019)
12.10.5 Sun Pharmaceutical Industries Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Gastritis Therapeutics Key Market Segments
Table Key Players Gastritis Therapeutics Covered
Table Global Gastritis Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Gastritis Therapeutics Market Size Market Share by Type 2014-2025
Figure Acid-Blocking Medicines Figures
Table Key Players of Acid-Blocking Medicines
Figure Antibiotics Figures
Table Key Players of Antibiotics
Figure Antacids Figures
Table Key Players of Antacids
Figure Histamine Blockers Figures
Table Key Players of Histamine Blockers
Figure Others Figures
Table Key Players of Others
Table Global Gastritis Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Gastritis Therapeutics Report Years Considered
Table Global Gastritis Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Gastritis Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Gastritis Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Gastritis Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Gastritis Therapeutics Market Share by Regions 2014-2019
Figure Global Gastritis Therapeutics Market Share by Regions 2014-2019
Figure Global Gastritis Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Gastritis Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Gastritis Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Gastritis Therapeutics Market Share by Manufacturers in 2018
Table Global Gastritis Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Gastritis Therapeutics Product/Solution/Service
Table Date of Enter into Gastritis Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Gastritis Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Gastritis Therapeutics Market Size Share by Type (2014-2019)
Figure Global Gastritis Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Gastritis Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Gastritis Therapeutics Market Size Share by Application (2014-2019)
Figure Global Gastritis Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Gastritis Therapeutics Revenue Market Share by Application in 2018
Figure United States Gastritis Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Gastritis Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Gastritis Therapeutics Market Share (2018-2019)
Table United States Gastritis Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Gastritis Therapeutics Market Share by Type (2014-2019)
Table United States Gastritis Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Gastritis Therapeutics Market Share by Application (2014-2019)
Figure Europe Gastritis Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Gastritis Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Gastritis Therapeutics Market Share (2018-2019)
Table Europe Gastritis Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Gastritis Therapeutics Market Share by Type (2014-2019)
Table Europe Gastritis Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Gastritis Therapeutics Market Share by Application (2014-2019)
Figure China Gastritis Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Gastritis Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Gastritis Therapeutics Market Share (2018-2019)
Table China Gastritis Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Gastritis Therapeutics Market Share by Type (2014-2019)
Table China Gastritis Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Gastritis Therapeutics Market Share by Application (2014-2019)
Figure Japan Gastritis Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Gastritis Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Gastritis Therapeutics Market Share (2018-2019)
Table Japan Gastritis Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Gastritis Therapeutics Market Share by Type (2014-2019)
Table Japan Gastritis Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Gastritis Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Gastritis Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Gastritis Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Gastritis Therapeutics Market Share (2018-2019)
Table Southeast Asia Gastritis Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Gastritis Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Gastritis Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Gastritis Therapeutics Market Share by Application (2014-2019)
Figure India Gastritis Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Gastritis Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Gastritis Therapeutics Market Share (2018-2019)
Table India Gastritis Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Gastritis Therapeutics Market Share by Type (2014-2019)
Table India Gastritis Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Gastritis Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Gastritis Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Gastritis Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Gastritis Therapeutics Market Share (2018-2019)
Table Central & South America Gastritis Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Gastritis Therapeutics Market Share by Type (2014-2019)
Table Central & South America Gastritis Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Gastritis Therapeutics Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Gastritis Therapeutics Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Gastritis Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Gastritis Therapeutics Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Gastritis Therapeutics Business (2014-2019)
Table AstraZeneca Recent Development
Table Novartis Company Details
Table Novartis Revenue in Gastritis Therapeutics Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Gastritis Therapeutics Business (2014-2019)
Table Novartis Recent Development
Table Cipla Company Details
Table Cipla Revenue in Gastritis Therapeutics Business (2014-2019)(Million US$)
Figure Cipla Revenue Growth Rate in Gastritis Therapeutics Business (2014-2019)
Table Cipla Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Gastritis Therapeutics Business (2014-2019)(Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Gastritis Therapeutics Business (2014-2019)
Table Abbott Laboratories Recent Development
Table Microbiotix Company Details
Table Microbiotix Revenue in Gastritis Therapeutics Business (2014-2019)(Million US$)
Figure Microbiotix Revenue Growth Rate in Gastritis Therapeutics Business (2014-2019)
Table Microbiotix Recent Development
Table Reddy's Laboratories Company Details
Table Reddy's Laboratories Revenue in Gastritis Therapeutics Business (2014-2019)(Million US$)
Figure Reddy's Laboratories Revenue Growth Rate in Gastritis Therapeutics Business (2014-2019)
Table Reddy's Laboratories Recent Development
Table Lupin Ltd Company Details
Table Lupin Ltd Revenue in Gastritis Therapeutics Business (2014-2019)(Million US$)
Figure Lupin Ltd Revenue Growth Rate in Gastritis Therapeutics Business (2014-2019)
Table Lupin Ltd Recent Development
Table Perrigo Pharmaceutical Company Details
Table Perrigo Pharmaceutical Revenue in Gastritis Therapeutics Business (2014-2019)(Million US$)
Figure Perrigo Pharmaceutical Revenue Growth Rate in Gastritis Therapeutics Business (2014-2019)
Table Perrigo Pharmaceutical Recent Development
Table Sun Pharmaceutical Industries Company Details
Table Sun Pharmaceutical Industries Revenue in Gastritis Therapeutics Business (2014-2019)(Million US$)
Figure Sun Pharmaceutical Industries Revenue Growth Rate in Gastritis Therapeutics Business (2014-2019)
Table Sun Pharmaceutical Industries Recent Development
Table Global Gastritis Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Gastritis Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Gastritis Therapeutics Market Size Share by Regions in 2025
Figure United States Gastritis Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Gastritis Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Gastritis Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Gastritis Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Gastritis Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Gastritis Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Gastritis Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Gastritis Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Gastritis Therapeutics Market Size by Product (2019-2025)
Figure Global Gastritis Therapeutics Market Size by Product in 2025
Table Global Gastritis Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Gastritis Therapeutics Market Size by Application (2019-2025)
Figure Global Gastritis Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の胃食道逆流症（GERD）治療薬市場：市場規模・現状・予測 Gastroesophageal reflux disease (GERD), also known as acid reflux, is a long-term condition where stomach contents come back up into the esophagus resulting in either symptoms or complications.Patent expiry of blockbuster drugs prescribed for the treatment of acid reflux disorders is majorly attribu…- 世界の核酸ベースの治療薬市場：市場規模・現状・予測 Gene therapy is a technique for correcting defective genes responsible for disease development. Nucleic acid-based molecules (deoxyribonucleic acid, complementary deoxyribonucleic acid, complete genes, ribonucleic acid, and oligonucleotides) are utilized as research tools within the broad borders of…
- 世界の獣医感染症治療薬市場：市場規模・現状・予測 In 2018, the global Veterinary Infectious Disease Therapeutics market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Veterinary Infectious Disease Therapeutics status, future forecast, growth opportu…
- 世界のスポーツ薬市場：市場規模・現状・予測 Sports medicine is a branch of medicine that deals with physical fitness and the treatment and prevention of injuries related to sports and exercise.Increasing incidences of the sports injuries and adoption of minimally invasive technologies are estimated to be the major factors that are augmenting …
- 世界のリソソーム蓄積症治療薬市場：市場規模・現状・予測 Lysosomal storage disorders is a group of genetic metabolic diseases caused by enzyme deficiencies in various body cells.The Gaucher's Diseases indication segment is expected to be the most dominant segment in global lysosomal storage diseases therapeutics market. Europe is estimated to be the domin…